Louisiana sues dialysis drug maker
BATON ROUGE, La. (AP) - Louisiana is suing drug maker Fresenius Medical Care North America and its nearly 100 Louisiana clinics over the use of two dialysis drugs - GranuFlo and NaturaLyte - that could contribute to fatal heart attacks.
The drugs have since been recalled by the federal government.
The lawsuit, filed in state district court in Baton Rouge by the state Attorney General's Office, says Fresenius violated Louisiana law in an effort to defraud dialysis clinics, physicians, the state and its residents.
Fresenius officials could not be reached for comment Friday.
The lawsuit seeks civil penalties of $5,000 per violation under Louisiana's Unfair Trade Practices and Consumer Protection Law. Louisiana is also asking the court to force Fresenius to pay back any profit made on the sale of GranuFlo.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
More than $160,000 raised in Unite for Our Heroes Telethon
West Baton Rouge school board offered free lunch for law enforcment
Hundreds gather for vigil for 3 slain officers
Financial help coming to families of fallen law enforcement heroes
Metro Council members oppose police residency requirements